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Abstract
BACKGROUND: Aseptic loosening of hip prosthesis as it occurs in clinical cases in human patients
was attributed to wear particles of the implants, the response of the tissue dominated by macrophages
and the production of inflammatory mediators and matrix degrading enzymes; however, the cascade of
events initiating the process and their interaction regarding the time course is still open and discussed
controversially. Therefore, the goal of this study was to establish an experimental animal model in sheep
allowing to follow the cascade of early mechanical and biochemical events within the interface
membrane and study the sequence of how they contribute to the pathological bone resorption necessary
for aseptic loosening of the implant. METHODS: A cemented modular system (Biomedtrix) was used as
a hip replacement in 24 adult Swiss Alpine sheep, with one group receiving a complete cement mantle
as controls (n = 12), and the other group a cement mantle with a standardized, lateral, primary defect in
the cement mantle (n = 12). Animals were followed over time for 2 and 8.5 months (n = 6 each). After
sacrifice, samples from the interface membranes were harvested from five different regions of the femur
and joint capsule. Explant cell cultures were performed and supernatant of cultures were tested and
assayed for nitric oxide, prostaglandin E2, caseinolytic and collagenolytic activity. RNA extraction and
quantification were performed for inducible nitric oxide synthase, cyclooxygenase-2, interleukin 1, and
interleukin 6. Overall differences between groups and time periods and interactions thereof were
calculated using a factorial analysis of variance (ANOVA). RESULTS: The development of an interface
membrane was noticed in both groups at both time points. However, in the controls the interface
membrane regressed in thickness and biological activity, while both variables increased in the
experimental group with the primary cement mantle defect over time. Nitric oxide (NO) and PGE2
concentrations were higher in the 8.5 months group (P < 0.0001) compared to the 2 months group with a
tendency for the unstable group to have higher concentrations. The same was true for collagenolytic
activity (P = 0.05), but not for caseinolytic activity that decreased over time (P < 0.0001).
CONCLUSION: In this study, a primary cement mantle defect of the femoral shaft elicited
biomechanical instability and biochemical changes over time in an experimental animal study in sheep,
that resembled the changes described at the bone cement-interface in aseptic loosening of total hip
prosthesis in humans. The early biochemical changes may well explain the pathologic bone resorption
and formation of an interface membrane as is observed in clinical cases. This animal model may aid in
future studies aiming at prevention of aseptic loosening of hip prosthesis and reflect some aspects of the
pathogenesis involved.
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Abstract
Background: Aseptic loosening of hip prosthesis as it occurs in clinical cases in human patients was attributed
to wear particles of the implants, the response of the tissue dominated by macrophages and the production of
inflammatory mediators and matrix degrading enzymes; however, the cascade of events initiating the process and
their interaction regarding the time course is still open and discussed controversially. Therefore, the goal of this
study was to establish an experimental animal model in sheep allowing to follow the cascade of early mechanical
and biochemical events within the interface membrane and study the sequence of how they contribute to the
pathological bone resorption necessary for aseptic loosening of the implant.
Methods: A cemented modular system (Biomedtrix) was used as a hip replacement in 24 adult Swiss Alpine
sheep, with one group receiving a complete cement mantle as controls (n = 12), and the other group a cement
mantle with a standardized, lateral, primary defect in the cement mantle (n = 12). Animals were followed over
time for 2 and 8.5 months (n = 6 each). After sacrifice, samples from the interface membranes were harvested
from five different regions of the femur and joint capsule. Explant cell cultures were performed and supernatant
of cultures were tested and assayed for nitric oxide, prostaglandin E2, caseinolytic and collagenolytic activity. RNA
extraction and quantification were performed for inducible nitric oxide synthase, cyclooxygenase-2, interleukin
1, and interleukin 6. Overall differences between groups and time periods and interactions thereof were
calculated using a factorial analysis of variance (ANOVA).
Results: The development of an interface membrane was noticed in both groups at both time points. However,
in the controls the interface membrane regressed in thickness and biological activity, while both variables
increased in the experimental group with the primary cement mantle defect over time. Nitric oxide (NO) and
PGE2 concentrations were higher in the 8.5 months group (P < 0.0001) compared to the 2 months group with a
tendency for the unstable group to have higher concentrations. The same was true for collagenolytic activity (P
= 0.05), but not for caseinolytic activity that decreased over time (P < 0.0001).
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BMC Musculoskeletal Disorders 2004, 5 http://www.biomedcentral.com/1471-2474/5/7Conclusion: In this study, a primary cement mantle defect of the femoral shaft elicited biomechanical instability
and biochemical changes over time in an experimental animal study in sheep, that resembled the changes
described at the bone cement-interface in aseptic loosening of total hip prosthesis in humans. The early
biochemical changes may well explain the pathologic bone resorption and formation of an interface membrane as
is observed in clinical cases. This animal model may aid in future studies aiming at prevention of aseptic loosening
of hip prosthesis and reflect some aspects of the pathogenesis involved.
Background
Aseptic loosening is reported as a major cause of failure in
total hip replacement. It is the result of a chronic inflam-
matory process characterized by the formation of fibrous
tissue or a synovial-like membrane between the bone and
the bone cement in cemented hip prosthesis and between
the metal implant and bone in cementless hip prosthesis
[1]. The so-called interface membrane is involved in the
pathologic bone resorption responsible for the loosening
of the prosthesis components [1,2] and typically consists
of a combination of fibrous tissue and macrophages [3].
The host specific local inflammatory response within the
bone has been shown to be elicited by both, micromotion
and wear particles [4]. The inflammatory response is char-
acterized by the activation of cellular mechanisms and the
increased production of cytokines like interleukin 1β (IL-
1β), interleukin 6 (IL-6), tumor necrosis factor a (TNF-α),
local inflammatory mediators as prostaglandin E2(PGE2)
and nitric oxide (NO), as well as neutral matrix metallo-
proteinases, such as collagenase (MMP1 and 13), and
stromelysin (MMP3) [5-15].
Cultured macrophages exposed to wear particles are capa-
ble of activating osteoblasts in vitro [16] that in turn seem
to be responsible for the recruitment and activation of
osteoclasts involved in phagocytosis and pathological
bone resorption [5,17]. The signal transduction among
these cells is mediated by the local factors mentioned
above, and was also shown to be connected to high mac-
rophage-colony stimulating factor found in periprosthetic
tissue in humans [15]. High levels of PGE2 and IL6 are
associated with bone resorption and osteoclast recruit-
ment and stimulation [18,19]. Bone matrix degradation
occurs after decalcification by hydrochloric acid and the
release of neutral matrix metalloproteinases (MMPs) from
lysozomes. In vivo the cellular responses with the local
cytokine and MMP expressions are dependent on the sam-
pling site from the interface membrane and may be varia-
ble and show only focal expression within the
periprosthetic tissue [8,13].
Experimental models mimicking aseptic loosening as it
occurs in clinical cases in human or canine patients are
rarely described in the literature [4,18,20-24]. Most of the
models favour the wear particles as the main cause of
aseptic loosening and add them to the bone site at the ini-
tial time of surgery. Alternatively a model based on alter-
ing the biomechanics by purposely placing a loose
implant [25]. These models prevent the study of the early
changes found in a well-fixed total hip prosthesis because
they don't simulate the real clinical situation. Recently a
rat model was introduced where intensive exercise imme-
diately after surgery initiated the formation of an interface
membrane at the bone cement interface similar to the one
observed in human patients [4]. This model seemed to
give an explanation for early events in aseptic loosening,
however, due to the rather excessive exercise regimen
immediately after surgery may also not reflect the real
clinical situation and may – for animal welfare reasons –
not be allowed to repeat in larger experimental animals.
Therefore, the goal of this study was to develop a new
experimental animal model in sheep that reflects a more
realistic clinical situation in humans (and also dogs) and
allows to study the early biochemical changes at the bone
cement interface in the time course of events. The model
was based on a primary cement mantle defect on the fem-
oral component of a hip prosthesis that was subsequently
expected to trigger micromotion and initiate the cascade
of cellular and biochemical events observed in clinical
cases of aseptic loosening. Biochemical changes at the
interface membranes were documented at two different
time points.
Table 1: Group distribution of experimental animals
Group Number of animals Time
Group I: complete cement mantle N = 6 2 months
N = 6 8.5 months
Group II: primary cement mantle defect N = 6 2 months
N = 6 8.5 monthsPage 2 of 13
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Experimental animal model
A total of 24 female Swiss alp adult sheep (age between 2–
4 years), weighing from 45.2 kg to 90.1 kg (average 60.8
kg), were divided in two groups (n = 12), where Group I
received a complete cement mantle and group II a cement
mantle with a standardized primary defect. Groups I and
II were further divided in two sub-groups based on time of
euthanasia at 2 and 8.5 months (Tab. 1).
Immediately before surgery the sheep received prophylac-
tically tetanus antiserum (Tetanus Serum, Veterinaria AG,
Zurich Switzerland), 7 mg/kg gentamicin (Streuli & Co
AG, Switzerland) and 30'000 lU/kg penicillin G (Hoechst
AG, Germany) intravenously. Anaesthesia was induced
after sedation with medetomidine (5 µg mg/kg, i.m.,
Domitor®, Orion-Farmos, Turku; Finland) with ketamine
(2 mg/kg Narketan®, Chassot AG, Switzerland) in combi-
nation with valium i.v. (Diazepam,0.01 mg/kg, Roche,
Switzerland) and was maintained with Isoflurane
(Forene®, Abbott AG, Baar, Switzerland) in 100% oxygen.
The antibiotic prophylaxis was continued for 5 days and
an analgesic (Rimadyl® Carpofen, 4 mg/kg i.v., Pfizer Inc.,
NY, USA) was administered once a day for three days after
surgery.
The sheep were randomly treated unilaterally with a total
hip replacement using a cemented modular system
(BioMedtrix, Allendale, NJ, USA). A routine craniolateral
approach and total hip replacement procedure was per-
formed to access the hip joint of the sheep and insert the
hip prosthesis [26-28]. Briefly, the femoral head was lux-
ated and the head removed at the femoral neck using a
template. Care was taken to match the length of the fem-
oral neck and the implant used. The femoral shaft was pre-
pared using a broach. After meticulous cleansing of the
bone marrow cavity and stopping of bleeding, slow, retro-
grade cement (Surgical Simplex P, Howmedica Interna-
tional Ltd, Limerick, Ireland) injection was performed
into the bone cavity avoiding the formation of air bub-
bles. While the cement was still in the liquid phase, a size
9 (?) femoral component was introduced into the femoral
shaft taking care achieving the correct position (antever-
sion) of the shaft. In Group I the prosthesis was fixed with
retrograde cement gun injection in order to achieve a
complete cement mantle (stable), whereas in group II
(unstable) a primary cement mantle defect was produced
using a small sized osteotome (Size 3, Aesculap, Tuttlin-
gen, Germany) introduced at the lateral side of the femo-
ral canal immediately after the liquid phase cement
injection. Just before complete polymerization of the
cement, the osteotome was removed leaving a standard-
ized primary defect at the lateral site of the shaft at a 90°
angle to the femoral neck and extending the full length of
the femoral component and 0.8 mm in width. After
polymerization of the cement, the implant stability was
assessed manually through the surgeon. All prostheses
were stable despite the cement mantle defect in group II.
After surgery the sheep were confined in small stalls in
groups of two sheep for 2–3 months. Thereafter, the ani-
mals of 8.5 months groups were transferred to larger sta-
bles where they were allowed to move free until the
termination of the experiment. All animal experiments
were conducted according to the laws of animal welfare in
Switzerland (application number: 56/99).
Sample collection and explant cultures
The femora and the joint capsule of each operated limb
were collected immediately after sacrifice of the animals.
The bones were put on ice until further processing. Trans-
verse bone sections were made of the femur with a special
bone saw (Exakt System, Norderstedt, Germany). In order
to get a good distribution and random selection of tissue
samples throughout the femoral shaft, the sections were
made according to five different regions. These regions
were delineated with the aid of the same radiographic
template used to determine the femoral implant size (R1
to R5) as described before (Fig 1). To facilitate sectioning
of the bone slices, the femoral metal component within
the cement mantle was carefully removed in a retrograde
fashion. The first cut in the femur was placed immediately
below the distal tip of the implant as measured by the
template (Region 1-R1). Then, the femoral metal compo-
nent was mobilized by placing an intramedullary Stein-
mann pin on the distal aspect of the stem while cautiously
tapping with a hammer on the tip of the pin until the
implant was freed from the cement mantle without break-
ing or loosening the bone cement itself. From each bone
region, another bone slice was cut and split in half longi-
tudinally such that the bone cement could be carefully
removed and the interface membrane between the bone
and the cement was exposed.
The interface membrane from each region was carefully
harvested with the aid of a curette. Half of this material
was immediately used for explant cultures, while the other
half was frozen in liquid nitrogen for mRNA
determination. The sample from each region was cultured
separately to obtain a representative distribution of the
whole femoral shaft.
The explant cultures were carried out in 24 well plates.
Briefly, tissue specimens were trimmed weighed (50 mg-
tissue/-explant culture) and washed in Gey's balanced salt
solution (Gibco Life Technologies, Basel, Switzerland).
The tissue was placed into these wells in the presence of 3
ml Ham's F12 nutrient medium containing 1% of penicil-
lin (100 units/ml) and streptomycin (100 µg/ml) (Fluka,
Buchs, Switzerland). Cultures were incubated for 48 hoursPage 3 of 13
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After this period, 3 ml of supernatant was carefully col-
lected from each well; divided in 5 aliquots and finally all
samples were frozen at -20°C until used for the assays.
The same procedure was performed for the joint capsule
(JC) of the operated femora.
Biochemical assays
All samples were run in duplicates.
Nitric oxide determinations
The release of NO was assessed using the Griess reaction
[29]. This reaction is based on a spectrophotometric
method where nitrite is measured as a stable end product
of NO representing 51.5 ± 3.5% of total NO [30]. The
reaction of naphtylenediamine dihydrochloride (0,1%)
and sulfanilamide (0.1%) in o-phosphoric acid in combi-
nation with nitrite results in a red-brownish color of
which the colorimetric density can be measured at 550
nm wavelength in a microplate reader.
Template of the femur with implanted prosthesisFigure 1
Template of the femur with implanted prosthesis. Schematic drawing of the femoral implant within the femur showing the 
regions were sections were made and samples were harvested (R1–R5).Page 4 of 13
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A commercially available PGE2 Immunoassay (R&D Sys-
tems, Oxon, England) was used as validated in sheep
before [31]. Briefly, this kit is a competitive assay in which
the PGE2 present in the sample competes with a fixed
amount of alkaline phosphatase-labeled PGE2 for sites on
a mouse monoclonal antibody that is bound to a 96-well
microplate with a goat anti-mouse antibody. The analysis
of all samples was performed in duplicates. Standard con-
centrations of PGE2 were run with a range of 0 – 5000 pg/
ml. Some of the samples had to be diluted due to the high
concentrations that were not within the sensitivity range
of the standard concentrations. The determination of the
optical density of each well was done using a microplate
reader set to 450 nm with wavelength correction set
between 570 nm and 590 nm. The intensity of the colour
of each well is inversely proportional to the concentration
of PGE2 in the sample.
Activity of neutral metalloproteinases
Collagenolytic and caseinolytic activities were determined
using an assay based on radiolabelled substrates (3H-ace-
tic anhydride, New England Nuclear, Boston, MA, USA)
[32]. Collagen type I (Vitrogen®, Collagen GmbH, Isman-
ing, Germany) was used as a substrate for collagenolytic
activity. Lyophilized casein served as substrate for detect-
ing caseinolytic activities. All substrates were dialyzed
with a 3H-acetic anhydride labeled reaction buffer con-
taining 30 mM Tris-HCl, 0.2 M NaCl and 5 mM CaCl2 and
adjusted to pH 7.4. The substrates were adjusted to a 1000
cpm/µg in the scintillation counter. Trypsin (10 µg) was
used as a positive control for caseinolytic activities and
bacterial collagenase (10 µg) for collagenolytic activity.
A solution of 20 µl of reaction buffer, 10 mul of ami-
nophenylmercuric acetate (APMA), 20 µl of conditioned
media and 25 µl of labeled substrate was used for assess-
ing collagenolytic activity. APMA was added to the sam-
ples to activate any latent form of neutral
metalloproteinases. The mixtures were incubated at 30°C
for 4 hours. The reaction was stopped by adding 10 µl of
o-phenanthroline in 50% p-dioxane diluted with reaction
buffer. The tubes were incubated for another hour at
35°C. Undigested collagen fibrils were precipitated with
75 µl of p-dioxane and centrifuged at 12000 × g for 10
minutes. Radioactivity of 50 µl was determined by liquid
scintillation.
For detection of caseinolytic activities a solution with 20
µl of reaction buffer, 10 µl of APMA, 20 µl of conditioned
media and 20 µl of labeled casein were made. The mixture
was incubated for 4 hours at 37°C. The termination of the
reaction was done by addition of 100 µl of 6% trichlora-
cetic acid and 50 µl of cold casein as a carrier for the assay.
Mixtures were centrifuged at 12000 × g for 10 minutes.
Radioactivity of 100 µl supernatant of casein was deter-
mined by liquid scintillation. Calculations for the activity
for each assay were based on the assumption that 1 U of
enzyme degrades 1 µg of substrate per minute.
RNA extraction
Interface membrane samples conserved at -80C were sub-
mitted to a procedure described by Nemeth at al. [33].
Briefly, samples were aseptically handled and put into a
guanidinethiocyanate solution and homogenized. After
short centrifugation the supernatant was removed and
transferred to ultracentrifuge tubes containing 1.2 ml of a
5.7 M cesium chloride solution. These tubes were ultra
centrifuged for 15–17 hours with 35000 rpm at 18° C.
The precipitate formed at the bottom of these tubes was
carefully manipulated and the supernatant removed. The
pellet was eluted and washed several times using different
steps with chloroform-butanol, ethanol 100%, sodium
acetate solution and ethanol 70%. Finally the pellets were
dried at room temperature under a lamp. The pellets were
eluted with RNA-se free water and total RNA was quanti-
fied on the spectrophotometer. The extracted RNA was
conserved at -80C.
RNA reverse transcription
The first strand cDNA from the total RNA was synthesized
with the Superscript Preamplification System (Gibco Life
Technologies, Basel, Switzerland). The samples were pre-
pared with Oligo (dT)12–18 and incubated for 10 min. at
70°C. The master mix was prepared and added to each
tube. The tubes were incubated for 5 minutes at 42°C. At
this point 1 µl of the Superscript Reverse transcriptase was
added to each tube. The tubes were incubated for 50 min
at 42°C. The reactions were terminated at 70°C for 15
min and the tubes chilled with ice. The content of the
tubes was brought down by brief centrifugation. One µl of
Rnase was added to each tube and incubated for 20 min
at 37°C. The tubes containing cDNA were conserved at -
20C.
Real-Time polymerase chain reaction (PCR)
The quantitative real time PCR was performed according
to an established procedure using the TaqMan system [34]
(PCR, ABI 7700, PE Applied Biosystems, Rotkreuz,
Switzerland). The tubes containing the cDNA were used in
the TaqMan real time PCR with primer pairs for standard
amplification. For this procedure glyceraldehyde-3 phos-
phate dehydrogenase (GAPDH; forward primer 5'-
TGGGCGTGAACCACGAG-3', reverse primer 5'-AGTC-
CCTCCACGATGCCA-3'), inducible nitric oxide synthase
(iNOS; forward primer 5'-TGACTTTCCAAGACACGCT-
TCA-3', reverse primer 5'-ACTTTTGGGATTCATGAT-
GGATG-3'), cyclooxygenase-2 (COX-2; forward primer 5'-
CATGCCGAATCGAGGTGTATGTA-3', reverse primer 5'-
CGGGAGTGGGTTTCAGGAGT-3'), interleukin 1β (IL-1β;Page 5 of 13
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3', reverse primer 5'-TGAGAAATCTGCAGCTGGATGT-3'),
interleukin 6 (IL-6; forward primer 5'-TCAGCTTATTT-
TCTGCCAGTGTCT-3', reverse primer 5'-TCATTAAGCA-
CATCGTCGACAAA) and oligonucleotide probes with a
fluorescent reporter dye (6-carboxy fluorescein-FAM) and
a quencher dye (6-carboxy-tetramethyl-rhodamine) were
used. The probes for the TaqMan for GAPDH, iNOS,
COX-2, IL-1β, IL-6 were 5'-FAM-3', 5'-FAM-AGAAG-
GCCAAAGGGGATCTCTCCTGCA-3', 5'-FAM-
TGAAAACTGTACACCTGAATTTCTGACAAGA-3', 5'-,
respectively.
The primers and probes were made according to pub-
lished sequences. TaqMan real time PCR was carried out
using the ABI Prism 7700 and started by a hot start PCR
amplification set at 95°C and the annealing period was of
1 min at 60°C. Forty five PCR cycles were allowed to
measure the development of the reporter dye. The thresh-
old cycle values, based on a constructed standard curve,
were used to determine the amount of target cDNA
(iNOS, COX-2, IL-1β, and IL-6) and the internal control
cDNA (GAPDH). Threshold cycle (CT) is defined as the
PCR cycle where a raise in reporter fluorescence over a
baseline signal can first be detected.
Statistics
The data of the different regions (R1-5) and capsule tissue
(JC) were collected individually for each region, but for
statistical evaluation thereafter the results were pooled for
each bone. Overall differences between groups (stable vs.
unstable) and time periods (2 vs.8.5 months) and interac-
tions thereof were calculated using a factorial analysis of
variance (ANOVA) (Statview, Cary, NC, USA). Correla-
tion coefficients were calculated and using z-transforma-
tion levels of significance were determined (P-values <
0.05).
Results
The formation of an interface membrane was demon-
strated in both, the one group with the complete and the
other with the cement mantle with the primary defect.
However, the interface membrane of both groups differed
in thickness as well as its presence at the two time points.
In the 2 months groups, the interface membranes were
similar in thickness although there was a tendency for the
group II with the primary cement mantle defect to be
thicker and more variable between the regions. Further-
more, the capsule that developed around the femoral neck
was thicker compared to the stable group I. In the 8
months groups, the interface membrane of the group with
the complete cement mantle had mostly regressed and
only in the most distal region (1R-1) seemed to be thicker
compared to the other regions. In contrast, the group with
the primary cement mantle defect showed a definite
thicker interface membrane at 8.5 months in all regions
and in 70% cases, the implant was already loosened and
could easily be pulled out. Despite an already loose
implant clinical lameness could not be detected in the
animals before they were sacrificed. In most cases, the
amount of tissue obtained was sufficient for performing
explant cell cultures and further biochemical analysis.
However, in some cases (especially in the stable group)
not enough membrane material could be harvested for
tRNA extraction.
Biochemical analysis (see Tab. 2)
Nitric oxide concentrations (Fig. 2)
Mean concentrations of NO varied significantly between
tissues harvested at 2 and 8 months (P < 0.0001), but not
between the group I with the complete cement mantle
and the group II with the primary defects. Nevertheless,
there was a tendency to have a higher concentration in the
group with the primary cement mantle defect. In all
groups standard deviations were very high.
Prostaglandin E2 concentrations (Fig. 3)
PGE2 analysis revealed differences in concentrations over
time but just missed statistical significances (P = 0.058). If
the stable groups I were compared at 2 and 8 months sta-
tistical significant differences were found (P = 0.0002),
which was not the case in the group II with the primary
cement mantle defect (P = 0.09). The same was true if
both groups were compared at 2 (P = 0.18) and 8.5
months (P = 0.27), however, there was a tendency for the
groups II with the primary cement mantle defect to show
higher concentrations. As with NO, standard deviations
were very high.
Table 2: Mean concentrations (NO, PGE2) and neutral metalloproteinases activity. Note high standard deviations in all groups.
Lab.value Group I 2 months Group I 8.5 months Group II 2 months Group II 8.5 months
NO µMol) 24.28 ± 16.9 175.33 ± 225.0 40.1 ± 44.9 235.31 ± 236.5
PGE2 (pg/L) 0.73 ± 1.7 298.9 ± 324.3 1.4 ± 1.7 1066.39 ± 371 7.4
Collagenolytic activity (IU/L) 0.001 ± 0.0 0.04 ± 0.1 0.3 ± 1.6 0.17 ± 0.3
Caseinolytic activity (IU/L) 0.32 ± 0.2 0.04 ± 0.1 0.52 ± 0.1 0.06 ± 0.1Page 6 of 13
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Overall differences of collagenolytic activity in media
from tissue samples of interface membranes were not sig-
nificant, although there was a tendency for the group II
with the primary cement mantle defect to show higher
values at 2 months and decrease over time. Significant dif-
ferences were demonstrated between the 2 groups at 8
months, where the group II with the primary cement man-
tle defect showed higher activities (P = 0.04). Statistical
significant differences were recorded for caseinolytic activ-
ities over time such that activities were higher at 2 months
for the stable group I compared to all other groups (P =
0.002). Individual differences between groups were signif-
icant at 2 (P < 0.0001), but not at 8 (P = 0.7) months.
qRT-PCR (Tab. 3)
The results obtained with the qRT-PCR were non-conclu-
sive (Tab. 3). The internal GAPDH control values were
already difficult to obtain indicated by a relative high
cycle numbers for mRNA detection (27–33 cycles).
Although mRNA could be detected for IL-1, IL-6, iNOS
and cox-2 in some of the samples, mean cycle numbers
were very high and thus, have to be interpreted with cau-
tion. mRNA of iNOS and IL-6 were detected in almost all
samples, while IL-1 and PGE2 were found in only very few
samples.
Correlations (Tab. 4)
Significant positive correlations were found for NO and
collagenolytic activities at 2 (P = 0.005) and 8 (P = 0.02)
months in the stable, and in the group with the primary
cement mantle defect at 8 months (P = 0.0009). The same
was true for NO and caseinolytic activities at 8 months (P
< 0.0001), collagenolytic and caseinolytic activities at 2
months (P = 0.014), as well as PGE2 and collagenolytic
activities at 2 months (P < 0.0001). All other correlations
were not significant. However, tendencies for negative
correlations were found for all other groups between NO
and PGE2, PGE2 and collagenolytic activities and colla-
Graph with NO concentrations and indication of statistical significancesFigure 2
Graph with NO concentrations and indication of statistical significances. Note that concentrations increased considerably in 
the 8 months group.Page 7 of 13
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nolytic activities all groups showed a tendency for positive
correlations.
Discussion
The experimental animal model with the primary cement
mantle defect enabled to follow the formation of an inter-
face membrane between bone and cement over time, as
well as to study early biochemical changes within the
interface tissue. There were biochemical differences
between the stable controls and the groups with the pri-
mary cement mantle defect such that the concentration of
the local mediators NO and PGE2 was elevated in the
group with the primary cement mantle defect and
increased in the time course over 2 and 8 months. The col-
lagenolytic activity was highest in the group with the pri-
mary cement mantle defect at 2 months, but stayed
relatively stable throughout the rest of the study.
Caseinolytic activity was highest in the control group and
decreased over time. Positive correlations were found
between NO and PGE2 concentrations and also in the 2
months groups for NO, PGE2 and the activity of the neu-
tral metalloproteinases.
Problems that arose from our experimental model in con-
junction to surgery were related to the standardization of
the surgical technique and post-operative management of
the sheep. The two fractures could have probably been
prevented with strict confinement in small boxes or by
using a suspension system in the first two weeks after sur-
gery. One of the difficulties of the model was to ensure the
repeatability of the cement mantle. Despite the use of new
cementing techniques (pressurization, retrograde cement
injection), the cement plug, the centralizer and the vac-
uum cement mixer were not available at the time of the
surgical procedures. These devices would most likely pro-
duce a more uniform cement mantle [35-38] and thus,
also a standardized defect. However, a recent twenty year
follow-up study using Charnley total hip arthroplasty
with these contemporary cement techniques showed no
significant clinical outcome improvement related to asep-
tic loosening using these new assets [39]. Therefore, it is
reasonable to assume that the outcome would have been
similar also in our experimental animals model.
Throughout the experiment the same size of osteotome
and surgical technique was used. All surgeries were per-
formed by the same, very experienced surgeon (Olm-
Concentrations of PGE2 at 2 and 8 monthsFigure 3
Concentrations of PGE2 at 2 and 8 months. Statisticalsignificances were not demonstrated due to high standard deviations.Page 8 of 13
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parallel to the femoral shaft at the exact same depth.
Therefore, it is safe to assume that the standardisation of
the defect was as accurate as possible. The development of
an interface membrane in the most distal (R1) and proxi-
mal region corresponded to the points of maximum shear
stress demonstrated with three-dimensional finite ele-
ment analysis in cemented hip prosthesis for dogs [40].
Another problem occurred with the quantitative RT-PCR,
where it was difficult to detect mRNA levels. Normally
cycle numbers to detect GAPDH vary between 20 – 24
cycles in our laboratory and depending on tissue differ lit-
tle between samples. In this study, however, cycle num-
bers were very high also for the internal control indicating
that difficulties were present isolating tRNA from tissue
samples (the higher cycle numbers, the less mRNA is
present). Although the procedure was repeated 2–3 times
(depending on availability of tissue), the detection limit
could not be improved. This was reflected also with the
numbers of cycles for IL-1, IL-6, iNOS and cox-2, although
mRNA of IL-6 and iNOS were at least detected in most of
the groups. The fact that mRNA levels of cox-2 could only
be detected in the 2 months control group despite the
high concentrations of PGE2 in the 8 months samples,
lead to the conclusion that technical problems were
responsible for these results. Interface tissue samples are
rich in collagen fibres but depending on localization low
in cell numbers. The latter was confirmed by histology
(unpublished data). The thicker the interface membrane,
the more collagen fibres were present and the lower were
cell numbers. It is likely that samples did not contain
enough cells to isolate sufficient total mRNA for later
detection of cox-2 or also IL-6. With the tissue in cell cul-
tures for several days, it could also be that the ubiquitous
mRNAse may have destroyed the mRNA within the cells
before it could be isolated. Nevertheless, IL-6 and iNOS
both were detected and confirm findings in other studies
dealing with local cytokine [5] and mediator [41]
upregulation
High standard deviations were recorded in all concentra-
tions of both local mediators (NO, PGE2) and neutral
metalloproteinase activity, more so than usually found in
our laboratory data. Since all samples were run in dupli-
cates and in most cases were repeated, the deviations can-
Cllagenolytic activity of neutral metalloproteinases in cell culture media decreased over time with a tendency to be higher in the roup with he primary cemen  mantle defectFigu e 4
Cllagenolytic activity of neutral metalloproteinases in cell culture media decreased over time with a tendency to be higher in 
the group with the primary cement mantle defect.Page 9 of 13
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laboratory practice. They rather reflect the local differ-
ences within the regions and the focal expression of the
mediators and enzyme activity along the femoral shaft. If
values of the different regions were compared individu-
ally, the deviations were generally less but due to small
sample numbers were also not statistically more signifi-
cant (unpublished data). In any case, concentrations of
NO and PGE2 were high and increased over time in this
experiment. These observations were in accordance with
some studies reported in the literature that showed that
both NO and PGE2 are associated with the induction and
maintenance of the chronic inflammatory reaction
[10,11]. The high levels of PGE2 could be attributed to the
high concentrations of NO in both groups. Some authors
have shown that NO can induce and regulate the synthesis
of cyclooxygenase 2 (cox-2), the enzyme responsible for
production of PGE2 in osteoblasts [42]. However, other
Caseinolytic activity in cell culture media of tissue from interface membranes was highest in the stable group at 2 month and decreased over timeFigure 5
Caseinolytic activity in cell culture media of tissue from interface membranes was highest in the stable group at 2 month and 
decreased over time. Differences were significant for all groups.
Table 3: quantitative mRNA detection (qRT-PCR) of IL-1, IL-6, iNOS and cox-2 using the TaqMan system. Negative values most likely 
represent technical difficulties in isolating mRNA of the tissue.
Expression GAPDH IL-1 IL-6 iNOS PGE2
Stable 2 months 32.5 0 36 0 0
Cement mantle defect 2 months 27 0 40 32 35
Stable 8.5 months 33 0 0 40 0
Cement mantle defect 8.5 months 29 33 35 35 0Page 10 of 13
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between those two mediators. It was shown that low con-
centrations of NO were associated with higher concentra-
tions of PGE2, while high concentrations of NO seemed
to lower PGE2 concentrations [43]. In this study, the con-
centrations of both local mediators were increased at 8.5
months after surgery compared to the 2 months group
similar to preliminary investigation with the same experi-
mental model in dogs [44] and confirming that these
local mediators play an active ole in the process of aseptic
loosening and development of interface membrane in
conjunction with a mechanically challenged hip prosthe-
sis. The high levels of NO and PGE2 concentrations cor-
roborate clinical findings in vitro [16,45] and in human
patients with aseptic loosening where high levels of pre-
cursor enzymes of PGE2 and NO (COX-2 and iNOS) in
the tissues macrophages of these tissues were demon-
strated [11]. Early bone resorption could be associated
with the high levels of PGE2, which is a known potent
inflammatory agent and is paramount in recruiting osteo-
clasts in combination with IL-6 [18,45,46].
The activity of neutral metalloproteinases is thought to be
indicative of the activities of several matrix metalloprotei-
nases. While earlier it was thought that collagenolytic
activity could be attributed to collagenases and caseino-
lytic activities to stromelysin, it was shown meanwhile
that mainly collagen can be degraded by several neutral
metalloproteinases (MMP1,8,13, MT-1)[47,48]. There-
fore, the attempt was made to support this data with
measurements of the MMP1 and MMP3 mRNA levels
from tissue of the interface membrane. As explained
above, this was only partially achieved. Nevertheless, the
relatively high caseinolytic and collagenolytic activity
found in our studies could well be related to the initial
inflammatory reaction caused by the surgical trauma
more evident after 2 months. This was more pronounced
in the control group at least for caseinolytic activities. Our
laboratory has previously shown that at least initially,
high levels of PGE2 could be potentially associated with
the inhibition of the enzymatic activity of MMP3, but over
time, the activity of stromelysin increased parallel to the
rising concentration of PGE2 in vitro [43,44]. This was not
the case in this study at least for caseinolytic activities.
Unfortunately, mRNA levels of the relevant MMP mRNA
could not be determined in this study due to the fact that
probes for sheep were not available at the time of the
experiments. This may have revealed different results
compared to caseinolytic activities that may be influenced
by inhibitors within the tissue [47,48]. In one study meas-
uring the mRNA expression of metalloproteinases in
interface membranes retrieved from aseptic loosened
prostheses in humans, MMP3 was highly expressed in the
tissues associated with bone resorption [13]. This was also
true for the mRNA expression of interstitial collagenase
(MMP-1) that has been regularly detected in the interface
membrane of patients with aseptic loosening [13]. Mean-
while high mRNA expressions of MMP1 and MMP3 were
also found with a similar experimental animal model in
our laboratory mimicking aseptic loosening of titanium-
aluminum-vanadium implants in sheep [49].
Conclusions
The experimental animal model where cemented hip
prosthesis were implanted with a primary cement mantle
defect in sheep lead to early biochemical changes at the
implant bone interface that may be triggering the cascade
of aseptic loosening of the metal implant. Although this
animal model in sheep is not equivalent to the clinical
condition of aseptic loosening in human patients, it may
allow time course studies at the bone implant interface in
the future and help to elicit the role of biomechanical sta-
bility, different cell types, cytokines and enzymes and
their interactions in the early cascade of aseptic loosening
in the future.
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